{
  "package" : "hl7.fhir.r4.core@4.0.1",
  "definition" : "Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm)\\nProjects: ISO 20776-1, ISO 20776-2\\r\\n\\n                        [Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.]\\r\\n\\n                        [Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.]\\r\\n\\n                        [Note 3: This class also indicates a \\\"buffer zone,\\\" to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.]\\r\\n\\n                        [Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]",
  "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#parent",
    "code" : "parent",
    "_implicit" : true,
    "valueCode" : "_ObservationInterpretationSusceptibility"
  } ],
  "codesystem" : "f0c8fd69-370c-5f88-82c4-74348ff8483f",
  "concept_id" : "d530f314-5614-53c1-8d53-7837ca1dd62d",
  "ancestors" : {
    "I" : 0,
    "_ObservationInterpretationSusceptibility" : 1
  },
  "id" : "be3eefe3-38e8-43e7-b94c-79a59a2b3da9",
  "code" : "I",
  "display" : "Intermediate",
  "version" : "2018-08-12"
}